8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Healthpeak reports flat adjusted FFO and raises 2026 guidance
Filed with the SEC on · Summarized by InvestorsBot
Healthpeak reported second-quarter 2026 net income of $0.08 per share and adjusted FFO of $0.46 per share, unchanged from the prior-year quarter, while Janus Living revenue rose 45% to $216 million. The company raised its 2026 adjusted FFO guidance by $0.02 at the midpoint to $1.73-$1.77 per share and generated $1.4 billion in proceeds from recapitalizations, loan repayments and dispositions through August 3, including approximately $1.025 billion from selling a 49% interest in an outpatient medical portfolio to Brookfield.